<DOC>
	<DOCNO>NCT03062501</DOCNO>
	<brief_summary>This study investigate safety , tolerability potential use three daily dose 30-40 mg/kg HU ( daily ) upon hospitalization painful vaso-occlusive crisis .</brief_summary>
	<brief_title>Hydroxyurea Emergency Room Lessen Pain Sickle Cell Crisis</brief_title>
	<detailed_description>Sickle cell anemia ( SCA ) hereditary hemoglobinopathy ; complication disease include , spleen enlargement , acute chest syndrome , pulmonary hypertension , stroke cumulative damage multiple organ , painful vaso-occlusive crisis ( VOC ) . In Brazil , 3,500 child born year DF , number individual sickle cell disease ( DF ) country estimate 25,000 30,000 ( ANVISA 2012 ; BRAZIL , 2012 ) . Hydroxyurea ( HU , hydroxycarbamide ) drug approve date American FDA use adult sickle cell disease . The drug modify disease process , improve hematological parameter hospitalization time patient , well frequency vaso-occlusive crises.In addition proven effect chronic use , experimental data indicate HU immediate anti-inflammatory effect . In addition proven effect chronic use , experimental data indicate HU immediate anti-inflammatory effect . This study investigate safety , tolerability potential use three daily dose 30-40 mg/kg HU ( daily ) upon hospitalization VOC .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Hydroxyurea</mesh_term>
	<criteria>Confirmed diagnosis homozygous sickle cell anemia ( HbSS ) . Hospitalization due onset uncomplicated vasoocclusive crisis ( pain scaleâ‰¥6 within last 24 h ) , confirm clinical evaluation . Documented write informed consent Confirmed suspect pregnancy . Initiation painful crisis &gt; 72h . Blood transfusion last 8 week . Admission Emergency Room due pain last 4 week . Neutrophil count &lt; 2.5 x 109/L platelet count &lt; 95.0 x 109 / L Hb &lt; 4.5 g / dL Weight &lt; 38 Kg &gt; 95 Kg . Interval longer 8h since arrival center . Nonconsent participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>